Bioasis Technologies Inc.
BIOAF · OTC
2/28/2022 | 2/28/2021 | 2/28/2020 | 2/28/2019 | |
|---|---|---|---|---|
| Market Cap | $19 | $27 | $15 | $25 |
| - Cash | $2 | $3 | $1 | $1 |
| + Debt | $2 | $0 | $1 | $0 |
| Enterprise Value | $19 | $24 | $15 | $23 |
| Revenue | $0 | $4 | $1 | $1 |
| % Growth | -99.1% | 572.5% | -57.4% | – |
| Gross Profit | -$1 | $3 | $1 | $1 |
| % Margin | -3,150.2% | 69.6% | 100% | 99.3% |
| EBITDA | -$4 | $0 | -$5 | -$5 |
| % Margin | -9,388.6% | 10.7% | -748% | -336.8% |
| Net Income | -$3 | $1 | -$4 | -$3 |
| % Margin | -7,846.5% | 17.1% | -669% | -244.3% |
| EPS Diluted | -0.041 | 0.01 | -0.065 | -0.061 |
| % Growth | -498.1% | 115.8% | -6.2% | – |
| Operating Cash Flow | -$4 | $2 | -$3 | -$3 |
| Capital Expenditures | $0 | $0 | $0 | -$0 |
| Free Cash Flow | -$4 | $2 | -$3 | -$3 |